Christian Hassig - Mar 27, 2024 Form 3 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Chief Scientific Officer
Signature
/s/ Jessica Oien, Attorney-in-Fact for Christian Hassig
Stock symbol
BOLD
Transactions as of
Mar 27, 2024
Transactions value $
$0
Form type
3
Date filed
3/27/2024, 08:08 PM
Next filing
Aug 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BOLD Common Stock 25.6K Mar 27, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BOLD Stock Option Mar 27, 2024 Common Stock 38.5K $3.12 Direct F1
holding BOLD Stock Option Mar 27, 2024 Common Stock 10.3K $3.71 Direct F2
holding BOLD Stock Option Mar 27, 2024 Common Stock 62.8K $4.10 Direct F3
holding BOLD Stock Option Mar 27, 2024 Common Stock 94.9K $4.10 Direct F4
holding BOLD Stock Option Mar 27, 2024 Common Stock 76.2K $8.19 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in substantially equal monthly installments until fully vested on October 28, 2024.
F2 The stock option vests as to 25% of the underlying shares on January 1, 2022, and vests as to the remaining underlying shares in 48 substantially equal monthly installments thereafter.
F3 The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021.
F4 The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.
F5 The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

Remarks:

Exhibit 24 - Power of Attorney.